Alison L. Hannah

Alison L. Hannah

DirectoratNeogenomics· In proxies 2023–2025

Alison L. Hannah sits on 2 public boards.

Experience

  1. NeogenomicsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +98%
  2. Rigel PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Rigel PharmaceuticalsPublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?